13G Filing: Woodford Investment Management and Northwest Biotherapeutics Inc (NWBO)

 

SCHEDULE 13G

CUSIP NO. 66737P600

SIGNATURE

 

After reasonable inquiry
and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete
and correct.

Dated: September 11, 2017

	WOODFORD INVESTMENT MANAGEMENT LTD
	By:	/s/ Chris Martin
		Name:	Chris Martin
		Title:	Head of Compliance and Authorized Signatory
	/s/ Neil Woodford
	Neil Woodford

  

This Schedule 13G is being jointly filed
by the Group. The Manager is an investment manager, authorized and regulated by the Financial Conduct Authority of the United Kingdom,
in the business of investment management. Mr. Woodford serves as the Head of Investment for the Manager. Mr. Woodford, as a controlling
person of the Manager, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended,
of the securities beneficially owned by the Manager. Securities reported on this Schedule 13G as being beneficially owned by the
Group were purchased on behalf of a client of the Manager.

 

Pursuant to Rule 13d-4, Mr. Woodford
declares that the filing of this Schedule 13G shall not be deemed an admission by him that he is, for the purposes of Section 13
of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Schedule 13G.